Writers, Readers and Erasers of RNA Modifications in Cancer.
暂无分享,去创建一个
Manel Esteller | M. Esteller | Alberto Bueno-Costa | R. Esteve-Puig | Rosaura Esteve-Puig | Alberto Bueno-Costa
[1] Nakul M. Shah,et al. Crosstalk between the RNA Methylation and Histone-Binding Activities of MePCE Regulates P-TEFb Activation on Chromatin. , 2018, Cell reports.
[2] Ling-Zhi Wang,et al. Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer , 2013, EMBO molecular medicine.
[3] Michaela Frye,et al. Stem cell function and stress response are controlled by protein synthesis , 2016, Nature.
[4] R. Lothe,et al. Identification of Novel Fusion Genes in Testicular Germ Cell Tumors. , 2016, Cancer research.
[5] H. Zhe,et al. FTO regulates the chemo‐radiotherapy resistance of cervical squamous cell carcinoma (CSCC) by targeting β‐catenin through mRNA demethylation , 2018, Molecular carcinogenesis.
[6] Samir Adhikari,et al. 5-methylcytosine promotes mRNA export — NSUN2 as the methyltransferase and ALYREF as an m5C reader , 2017, Cell Research.
[7] E. Kool,et al. Fluorescence Monitoring of the Oxidative Repair of DNA Alkylation Damage by ALKBH3, a Prostate Cancer Marker. , 2016, Journal of the American Chemical Society.
[8] Dan Xie,et al. 5-methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs , 2019, Nature Cell Biology.
[9] F. Rottman,et al. Characterization and partial purification of mRNA N6-adenosine methyltransferase from HeLa cell nuclei. Internal mRNA methylation requires a multisubunit complex. , 1994, The Journal of biological chemistry.
[10] J. Taylor,et al. Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[11] B. Job,et al. Genomic Aberrations in Lung Adenocarcinoma in Never Smokers , 2010, PloS one.
[12] F. Setién,et al. Epigenetic inactivation of the splicing RNA-binding protein CELF2 in human breast cancer , 2019, Oncogene.
[13] Akihiro Kuno,et al. TRMT2A is a novel cell cycle regulator that suppresses cell proliferation. , 2019, Biochemical and biophysical research communications.
[14] Wengong Wang,et al. Overexpression of NSUN2 by DNA hypomethylation is associated with metastatic progression in human breast cancer , 2016, Oncotarget.
[15] R Engers,et al. DKC1 overexpression associated with prostate cancer progression , 2009, British Journal of Cancer.
[16] T. Ishiwata,et al. Elevated expression level of 60-kDa subunit of tRNA-guanine transglycosylase in colon cancer. , 2004, Cancer letters.
[17] J. Nadeau,et al. Sleeping Beauty Insertional Mutagenesis in Mice Identifies Drivers of Steatosis-Associated Hepatic Tumors. , 2017, Cancer research.
[18] Y. Jaiswal,et al. Modulation in the activity of lactate dehydrogenase and level of c-Myc and c-Fos by modified base queuine in cancer , 2008 .
[19] Zhike Lu,et al. m6A RNA Methylation Regulates the Self-Renewal and Tumorigenesis of Glioblastoma Stem Cells , 2017, Cell reports.
[20] Sebastian A. Leidel,et al. Codon-specific translation reprogramming promotes resistance to targeted therapy , 2018, Nature.
[21] Chao Xu,et al. YTH Domain: A Family of N6-methyladenosine (m6A) Readers , 2018, Genom. Proteom. Bioinform..
[22] Seung-Yong Jeong,et al. RNA editing in RHOQ promotes invasion potential in colorectal cancer , 2014, The Journal of experimental medicine.
[23] Y. Liu,et al. FTO expression is associated with the occurrence of gastric cancer and prognosis. , 2017, Oncology reports.
[24] John G Doench,et al. Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade , 2018, Nature.
[25] Tomasz K. Wirecki,et al. MODOMICS: a database of RNA modification pathways. 2017 update , 2017, Nucleic Acids Res..
[26] P. Pandolfi,et al. Epigenetic loss of RNA-methyltransferase NSUN5 in glioma targets ribosomes to drive a stress adaptive translational program , 2019, Acta Neuropathologica.
[27] M. Dawson,et al. Cancer Epigenetics: From Mechanism to Therapy , 2012, Cell.
[28] G. Kong,et al. Direct determination of nucleosides in the urine of patients with breast cancer using column-switching liquid chromatography-tandem mass spectrometry. , 2006, Biomedical chromatography : BMC.
[29] L. Crinò,et al. DKC1 gene mutations in human sporadic cancer. , 2013, Histology and histopathology.
[30] 이화영. X , 1960, Chinese Plants Names Index 2000-2009.
[31] Leilei Chen,et al. Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma , 2013, Nature Medicine.
[32] J. Cerhan,et al. Variation in TRMT11 gene as a prognostic marker in advanced-stage castrate-resistant prostate cancer (CRPC) patients. , 2015 .
[33] Xiandong Lin,et al. Association of polymorphisms and haplotype in the region of TRIT1, MYCL1 and MFSD2A with the risk and clinicopathological features of gastric cancer in a southeast Chinese population. , 2013, Carcinogenesis.
[34] Jie Jin,et al. FTO Plays an Oncogenic Role in Acute Myeloid Leukemia as a N6-Methyladenosine RNA Demethylase. , 2017, Cancer cell.
[35] J. Steitz,et al. Methyltransferase-like protein 16 binds the 3′-terminal triple helix of MALAT1 long noncoding RNA , 2016, Proceedings of the National Academy of Sciences.
[36] Yuen Gao,et al. HBXIP-elevated methyltransferase METTL3 promotes the progression of breast cancer via inhibiting tumor suppressor let-7g. , 2018, Cancer letters.
[37] F. Du,et al. YTH domain family 2 orchestrates epithelial-mesenchymal transition/proliferation dichotomy in pancreatic cancer cells , 2017, Cell cycle.
[38] Marcin Feder,et al. MODOMICS: a database of RNA modification pathways , 2005, Nucleic Acids Res..
[39] A. Karamyshev,et al. Lost in Translation: Ribosome-Associated mRNA and Protein Quality Controls , 2018, Front. Genet..
[40] Lingeng Lu,et al. Association of tRNA methyltransferase NSUN2/IGF-II molecular signature with ovarian cancer survival. , 2017, Future oncology.
[41] U. Pastorino,et al. Identification and functional characterization of the candidate tumor suppressor gene TRIT1 in human lung cancer , 2005, Oncogene.
[42] L. Ellis,et al. APOBEC3G promotes liver metastasis in an orthotopic mouse model of colorectal cancer and predicts human hepatic metastasis. , 2011, The Journal of clinical investigation.
[43] M. Esteller,et al. SnapShot: Messenger RNA Modifications , 2018, Cell.
[44] S. Chambers,et al. Human ALKBH3-induced m1A demethylation increases the CSF-1 mRNA stability in breast and ovarian cancer cells. , 2019, Biochimica et biophysica acta. Gene regulatory mechanisms.
[45] Yuan Ren,et al. Overexpression of TRMT12 may independently predict poor overall survival in patients with head and neck squamous cell carcinoma , 2019, OncoTargets and therapy.
[46] Chuan He,et al. Where, When, and How: Context-Dependent Functions of RNA Methylation Writers, Readers, and Erasers. , 2019, Molecular cell.
[47] Chuan He,et al. m6A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program. , 2017, Cancer cell.
[48] J. Tainer,et al. Human ABH3 structure and key residues for oxidative demethylation to reverse DNA/RNA damage , 2006, The EMBO journal.
[49] Andrew J. Bannister,et al. METTL1 Promotes let-7 MicroRNA Processing via m7G Methylation , 2019, Molecular cell.
[50] Chuan He,et al. Anti-tumor immunity controlled through mRNA m6A and YTHDF1 in dendritic cells , 2019, Nature.
[51] M. Kupiec,et al. Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq , 2012, Nature.
[52] M. Schaefer,et al. Azacytidine inhibits RNA methylation at DNMT2 target sites in human cancer cell lines. , 2009, Cancer research.
[53] Jun Chen,et al. METTL1 overexpression is correlated with poor prognosis and promotes hepatocellular carcinoma via PTEN , 2019, Journal of Molecular Medicine.
[54] Fedorov Na,et al. Urinary excretion of purine bases and pseudouridine normal human and in cancer patients before and after radiotherapy. 1 , 1969 .
[55] Yusuke Nakamura,et al. A novel human tRNA-dihydrouridine synthase involved in pulmonary carcinogenesis. , 2005, Cancer research.
[56] Zhike Lu,et al. m6A mRNA demethylase FTO regulates melanoma tumorigenicity and response to anti-PD-1 blockade , 2019, Nature Communications.
[57] Richard L. Mercer,et al. WHERE Ω , 1973, APLQ.
[58] Tao Pan,et al. Dynamic RNA Modifications in Gene Expression Regulation , 2017, Cell.
[59] Yue Sheng,et al. METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m6A Modification. , 2017, Cell stem cell.
[60] K. Shimada,et al. PCA-1/ALKBH3 contributes to pancreatic cancer by supporting apoptotic resistance and angiogenesis. , 2012, Cancer research.
[61] Stefan Hüttelmaier,et al. Recognition of RNA N6-methyladenosine by IGF2BP Proteins Enhances mRNA Stability and Translation , 2018, Nature Cell Biology.
[62] W. Cohn,et al. Some results of the applications of ion-exchange chromatography to nucleic acid chemistry. , 1951, Journal of cellular physiology. Supplement.
[63] F. Setién,et al. Epigenetic loss of the RNA decapping enzyme NUDT16 mediates C-MYC activation in T-cell acute lymphoblastic leukemia , 2017, Leukemia.
[64] T. Jensen,et al. Escaping nuclear decay: the significance of mRNA export for gene expression , 2018, Current Genetics.
[65] O. Abdel-Wahab,et al. Altered RNA Processing in Cancer Pathogenesis and Therapy. , 2019, Cancer discovery.
[66] Yanli Gu,et al. CDK5RAP1 targeting NF-κB signaling pathway in human malignant melanoma A375 cell apoptosis , 2018, Oncology letters.
[67] Chuan He,et al. m6A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer , 2018, Nature Cell Biology.
[68] A. Dutra,et al. Chromosome 8 BAC array comparative genomic hybridization and expression analysis identify amplification and overexpression of TRMT12 in breast cancer , 2007, Genes, chromosomes & cancer.
[69] Francine E. Garrett-Bakelman,et al. The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal and leukemia cells , 2017, Nature Medicine.
[70] P. Pandolfi,et al. The Epitranscriptome of Noncoding RNAs in Cancer. , 2017, Cancer discovery.
[71] G. G. Stokes. "J." , 1890, The New Yale Book of Quotations.
[72] Li Wei,et al. CDK5RAP1 deficiency induces cell cycle arrest and apoptosis in human breast cancer cell line by the ROS/JNK signaling pathway. , 2015, Oncology reports.
[73] M. Öhman,et al. ADAR1 Editing and its Role in Cancer , 2018, Genes.
[74] Lai Wei,et al. RNA N6‐methyladenosine methyltransferase‐like 3 promotes liver cancer progression through YTHDF2‐dependent posttranscriptional silencing of SOCS2 , 2018, Hepatology.
[75] Thomas de Quincey. [C] , 2000, The Works of Thomas De Quincey, Vol. 1: Writings, 1799–1820.
[76] P. Alam. ‘G’ , 2021, Composites Engineering: An A–Z Guide.
[77] Sebastian A. Leidel,et al. Elp3 links tRNA modification to IRES-dependent translation of LEF1 to sustain metastasis in breast cancer , 2016, The Journal of experimental medicine.
[78] Chuanzhao Zhang,et al. Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m6A-demethylation of NANOG mRNA , 2016, Proceedings of the National Academy of Sciences.
[79] David N. Rider,et al. Germline predictors of androgen deprivation therapy response in advanced prostate cancer. , 2012, Mayo Clinic proceedings.
[80] Yang Shi,et al. m6A RNA methylation regulates the UV-induced DNA damage response , 2016, Nature.
[81] Joseph,et al. Characterization and Partial Purification of mRNA NG-Adenosine Methyltransferase from HeLa Cell Nuclei , 2001 .
[82] James E. Bradner,et al. R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m6A/MYC/CEBPA Signaling , 2018, Cell.
[83] Wen-He Huang,et al. Cytoplasmic Skp2 Expression Is Associated with p-Akt1 and Predicts Poor Prognosis in Human Breast Carcinomas , 2012, PloS one.
[84] X. Zuo,et al. RNA editing of SLC22A3 drives early tumor invasion and metastasis in familial esophageal cancer , 2017, Proceedings of the National Academy of Sciences.
[85] D. Tenen,et al. ADAR-Mediated RNA Editing Predicts Progression and Prognosis of Gastric Cancer. , 2016, Gastroenterology.
[86] F. Watt,et al. The RNA Methyltransferase Misu (NSun2) Mediates Myc-Induced Proliferation and Is Upregulated in Tumors , 2006, Current Biology.
[87] F. Setién,et al. Gene amplification-associated overexpression of the RNA editing enzyme ADAR1 enhances human lung tumorigenesis , 2015, Oncogene.
[88] John S. Mattick,et al. The RNA modification landscape in human disease , 2017, RNA.
[89] C. Cho,et al. m1A Regulated Genes Modulate PI3K/AKT/mTOR and ErbB Pathways in Gastrointestinal Cancer , 2019, Translational oncology.
[90] P. Alam. ‘V’ , 2021, Composites Engineering: An A–Z Guide.
[91] Lv-yun Zhu,et al. Spatial organization of enzymes to enhance synthetic pathways in microbial chassis: a systematic review , 2018, Microbial Cell Factories.
[92] J. Clohessy,et al. Dyskerin expression influences the level of ribosomal RNA pseudo‐uridylation and telomerase RNA component in human breast cancer , 2006, The Journal of pathology.
[93] Tsuyoshi Murata,et al. {m , 1934, ACML.
[94] Bifeng Yuan,et al. ALKBH1 demethylates N3-methylcytidine in mRNA of mammals. , 2019, ACS chemical biology.
[95] Kaori Takai,et al. RNA helicase YTHDC2 promotes cancer metastasis via the enhancement of the efficiency by which HIF-1α mRNA is translated. , 2016, Cancer letters.
[96] N. Fedorov,et al. [Urinary excretion of purine bases and pseudouridine normal human and in cancer patients before and after radiotherapy. 1]. , 1969, Radiobiologia, radiotherapia.
[97] S. Robson,et al. Human RNA Methyltransferase BCDIN3D Regulates MicroRNA Processing , 2012, Cell.
[98] Schraga Schwartz,et al. Perturbation of m6A writers reveals two distinct classes of mRNA methylation at internal and 5' sites. , 2014, Cell reports.
[99] P. Alam. ‘L’ , 2021, Composites Engineering: An A–Z Guide.
[100] Chuan He,et al. RNA cytosine methylation and methyltransferases mediate chromatin organization and 5-azacytidine response and resistance in leukaemia , 2018, Nature Communications.
[101] Peter Kraft,et al. Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types. , 2016, Cancer discovery.
[102] A. Muñoz-Barrutia,et al. Multiscale in situ analysis of the role of dyskerin in lung cancer cells. , 2013, Integrative biology : quantitative biosciences from nano to macro.
[103] John E. J. Rasko,et al. Genetic alterations of m6A regulators predict poorer survival in acute myeloid leukemia , 2017, Journal of Hematology & Oncology.
[104] M. McNutt,et al. GSK-3β–Regulated N-Acetyltransferase 10 Is Involved in Colorectal Cancer Invasion , 2014, Clinical Cancer Research.
[105] Y. Miao,et al. ALKBH5 Inhibits Pancreatic Cancer Motility by Decreasing Long Non-Coding RNA KCNK15-AS1 Methylation , 2018, Cellular Physiology and Biochemistry.
[106] Michael L. Gatza,et al. An integrated genomics approach identifies drivers of proliferation in luminal subtype human breast cancer , 2014, Nature Genetics.
[107] Jonas Korlach,et al. The birth of the Epitranscriptome: deciphering the function of RNA modifications , 2012, Genome Biology.
[108] J. Saurin,et al. p53 Acts as a Safeguard of Translational Control by Regulating Fibrillarin and rRNA Methylation in Cancer , 2013, Cancer Cell.
[109] J. Coller,et al. Structural and molecular mechanisms for the control of eukaryotic 5′–3′ mRNA decay , 2018, Nature Structural & Molecular Biology.
[110] P. Alam. ‘A’ , 2021, Composites Engineering: An A–Z Guide.
[111] Zhifu Sun,et al. Genetic Variation Predicting Cisplatin Cytotoxicity Associated with Overall Survival in Lung Cancer Patients Receiving Platinum-Based Chemotherapy , 2011, Clinical Cancer Research.
[112] Olivier Elemento,et al. Reversible methylation of m6Am in the 5′ cap controls mRNA stability , 2016, Nature.
[113] A. Feuchtinger,et al. Mitochondrial Alkbh1 localizes to mtRNA granules and its knockdown induces the mitochondrial UPR in humans and C. elegans , 2019, Journal of Cell Science.
[114] Maurizio Pellecchia,et al. ADAR1 Activation Drives Leukemia Stem Cell Self-Renewal by Impairing Let-7 Biogenesis. , 2016, Cell stem cell.
[115] Liping Xie,et al. Downregulation of N6-methyladenosine binding YTHDF2 protein mediated by miR-493-3p suppresses prostate cancer by elevating N6-methyladenosine levels , 2017, Oncotarget.
[116] V. Cowling,et al. Oncogenic PIK3CA mutations increase dependency on the mRNA cap methyltransferase, RNMT, in breast cancer cells , 2019, Open Biology.
[117] Gang Chen,et al. Overexpression of the fat mass and obesity associated gene (FTO) in breast cancer and its clinical implications. , 2015, International journal of clinical and experimental pathology.